Functional observation after morphine withdrawal: effects of SJP-005
RATIONALE AND OBJECTIVE: SJP-005 (ketotifen and ibuprofen) is being developed as a potential new treatment for opioid withdrawal. Three studies were conducted to evaluate the early phase (acute, day 1) and late phase (days 2–12) effects of SJP-005 on discontinuation-induced morphine withdrawal. METH...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139893/ https://www.ncbi.nlm.nih.gov/pubmed/33555386 http://dx.doi.org/10.1007/s00213-021-05771-5 |